ATPW
MRNA icon

Ashton Thomas Private Wealth’s Moderna MRNA Stock Holding History

Ashton Thomas Private Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-221
Closed -$26.2K – 1359
2024
Q2 		$26.2K Buy
+221
New +$28K ﹤0.01% 1084

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ashton Thomas Private Wealth's MRNA Position: Q3 2024 in Review

Ashton Thomas Private Wealth sold out of Moderna (MRNA) in Q3 2024, closing a stake of 221 shares — an estimated $26.2K sold.

Ashton Thomas Private Wealth first reported a position in MRNA in Q2 2024 and held it in 1 quarter. The position peaked at $26.2K in Q2 2024. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Ashton Thomas Private Wealth reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 221 Moderna shares in Q3 2024, an estimated $26.2K.
  • Ashton Thomas Private Wealth first reported a position in Moderna in Q2 2024 and held it in 1 quarter.
  • Ashton Thomas Private Wealth's Moderna position peaked at $26.2K in Q2 2024.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2024, filed 5 Nov 2024.